Die Anmeldung erfolgt direkt auf der Seminarwebseite von HESKA:

The Power of Nucleosomes: A Breakthrough in Canine Lymphoma Monitoring and Treatment - Heska

Sie erhalten nach Ihrer Anmeldung alle erforderlichen Informationen (Log-in-Daten etc.) per E-Mail von unserem Mutterkonzern HESKA.

Canine lymphoma is a common and debilitating disease that up until now has been a struggle to detect early and monitor through treatment. Those difficult days are nearing an end thanks to recent advances in epigenetics. Attend this free 1-hr webinar to hear about Heska Nu.Q® Canine Cancer Screen and Monitor, a breakthrough in cancer monitoring in-clinic, from Veterinary Oncologist Dr. Heather Wilson-Robles, Chief Medical Officer of Volition Veterinary and Past President of the Veterinary Cancer Society. Dr. Wilson-Robles will discuss recent research into utilizing Nu.Q® to monitor patients undergoing treatment for lymphoma.

Attend this webinar to learn about:

• Current methods to monitor treatment and disease progress
• Clinical study on monitoring lymphoma progression using nucleosomes
• Discussion on how to use Nu.Q® to guide treatment and monitor progress
• Comparison between nucleosomes, c-reactive protein, and thymidine kinase